Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice?

about

Free Urinary Desmosine and Isodesmosine as COPD Biomarkers: The Relevance of Confounding Factors.

P2860

Q41434441-FE1D8830-1EA5-4CD8-99BA-79771203B405

P2860

Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice?

Item

http://www.wikidata.org/entity/Q38109057

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Blood specimen biomarkers of i ...... patients in clinical practice?

@en

type

Item

label

Blood specimen biomarkers of i ...... patients in clinical practice?

@en

prefLabel

Blood specimen biomarkers of i ...... patients in clinical practice?

@en

P1476

Blood specimen biomarkers of i ...... patients in clinical practice?

@en

P2093

Sabina Skrgat Kristan

http://www.w3.org/2001/XMLSchema#string

P2860

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

Acute-phase proteins and other systemic responses to inflammation

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5

Desmosine as a biomarker of elastin degradation in COPD: current status and future directions.

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

VEGF: an update on biological and therapeutic aspects.

ATS statement: guidelines for the six-minute walk test.

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

P2888

s00005-013-0237-y

P304

469-481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00005-013-0237-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236908197

http://www.w3.org/2001/XMLSchema#string

P6179

1052905549

http://www.w3.org/2001/XMLSchema#string

P698

23703244

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

biomarker

Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice?

about

P2860

P2860

Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921